Michigan Medicine Inaugural Advanced Genitourinary Cancers Symposium

Saturday, November 9, 2024, 7:00 AM - 4:40 PM EST, The Sheraton, 3200 Boardwalk Dr, Ann Arbor, MI


AMA PRA Category 1 Credits™ (7.25 hours), Non-Physician Attendance (7.25 hours)

The Michigan Medicine Rogel Cancer Center (UMRCC) is an NCI-designated comprehensive cancer center with a history of excellence in cancer care, education, and research. After this activity, participants will be able to utilize the current state-of-the-art updates in the diagnosis, risk stratification, and treatment of advanced (metastatic) genitourinary cancers including prostate, renal, bladder, and testis. They will also be able to access information and enroll advanced genitourinary cancer patients in current state-of-the-art, groundbreaking clinical trials at Michigan Medicine.

The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

For questions or concerns, please contact:
Jenny Fossum at [email protected]

Accessibility Statement
 
The University of Michigan Medical School is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Activity Coordinator.

Mitigation of Relevant Financial Relationships

The University of Michigan Medical School adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to control the content of a CE activity, including faculty, planners, or others are required to disclose all relevant financial relationships with ineligible entities. All relevant financial relationships have been mitigated prior to the commencement of the activity.

Saturday, November 9, 2024